CN107837309A - A kind of composition with auxiliary hyperglycemic function and preparation method thereof - Google Patents
A kind of composition with auxiliary hyperglycemic function and preparation method thereof Download PDFInfo
- Publication number
- CN107837309A CN107837309A CN201710820373.7A CN201710820373A CN107837309A CN 107837309 A CN107837309 A CN 107837309A CN 201710820373 A CN201710820373 A CN 201710820373A CN 107837309 A CN107837309 A CN 107837309A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- ginseng
- rehmannia
- radix astragali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 86
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 230000003345 hyperglycaemic effect Effects 0.000 title claims abstract description 12
- 244000302512 Momordica charantia Species 0.000 claims abstract description 85
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 85
- 241000208340 Araliaceae Species 0.000 claims abstract description 84
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 84
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 84
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 84
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 84
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 84
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 84
- 235000008434 ginseng Nutrition 0.000 claims abstract description 84
- 239000009636 Huang Qi Substances 0.000 claims abstract description 81
- 241000405414 Rehmannia Species 0.000 claims abstract description 71
- 239000000706 filtrate Substances 0.000 claims abstract description 69
- 239000000843 powder Substances 0.000 claims abstract description 63
- 238000001914 filtration Methods 0.000 claims abstract description 53
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 155
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000000047 product Substances 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 13
- 244000269722 Thea sinensis Species 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 8
- 239000007902 hard capsule Substances 0.000 claims description 7
- 230000036541 health Effects 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000000605 extraction Methods 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 21
- 239000002994 raw material Substances 0.000 abstract description 7
- 238000005453 pelletization Methods 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 239000007921 spray Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 47
- 239000008280 blood Substances 0.000 description 47
- 239000008103 glucose Substances 0.000 description 45
- 239000000284 extract Substances 0.000 description 37
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 32
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 30
- 238000010992 reflux Methods 0.000 description 30
- 239000006071 cream Substances 0.000 description 29
- 241000699666 Mus <mouse, genus> Species 0.000 description 25
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 24
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 24
- 239000000546 pharmaceutical excipient Substances 0.000 description 24
- 235000010357 aspartame Nutrition 0.000 description 21
- 235000019359 magnesium stearate Nutrition 0.000 description 21
- 238000004140 cleaning Methods 0.000 description 20
- 230000037396 body weight Effects 0.000 description 18
- 238000001035 drying Methods 0.000 description 17
- 238000000227 grinding Methods 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 16
- 201000001421 hyperglycemia Diseases 0.000 description 15
- 238000011084 recovery Methods 0.000 description 15
- 239000006228 supernatant Substances 0.000 description 15
- 230000006837 decompression Effects 0.000 description 14
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 14
- 238000001694 spray drying Methods 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 239000008108 microcrystalline cellulose Substances 0.000 description 13
- 229940016286 microcrystalline cellulose Drugs 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 108010011485 Aspartame Proteins 0.000 description 11
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 11
- 239000000605 aspartame Substances 0.000 description 11
- 229960003438 aspartame Drugs 0.000 description 11
- 238000007796 conventional method Methods 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 238000003556 assay Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000000291 postprandial effect Effects 0.000 description 9
- 239000011122 softwood Substances 0.000 description 9
- 210000002700 urine Anatomy 0.000 description 9
- 235000020985 whole grains Nutrition 0.000 description 9
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 229940125396 insulin Drugs 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 239000007901 soft capsule Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 4
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 4
- 235000021286 stilbenes Nutrition 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229940057948 magnesium stearate Drugs 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 229940123208 Biguanide Drugs 0.000 description 2
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- 241000405911 Rehmannia glutinosa Species 0.000 description 2
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 229940107666 astragalus root Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000004283 biguanides Chemical class 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- -1 Ah This Ba Tian Substances 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 1
- 102100036264 Glucose-6-phosphatase catalytic subunit 1 Human genes 0.000 description 1
- 101710099339 Glucose-6-phosphatase catalytic subunit 1 Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 101710176384 Peptide 1 Proteins 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000007674 genetic toxicity Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N sodium azide Substances [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of composition with auxiliary hyperglycemic function and preparation method thereof, said composition is prepared by 5 70 parts of ginseng, 10 80 parts of the Radix Astragali, 300 1500 parts of balsam pear, 5 80 parts of the dried rhizome of rehmannia, 5 70 parts of Fructus Corni, 5 80 parts of the root of kudzu vine for primary raw material, and its preparation method can include:Ginseng, the Radix Astragali, the taste traditional Chinese medicine extraction of the dried rhizome of rehmannia three are concentrated and spray into fine powder, and the root of kudzu vine, Fructus Corni extraction are concentrated and spray into fine powder, and after filtering of squeezing the juice powder processed is dried respectively in filtrate and filter residue by balsam pear, and all fine powders are well mixed into the steps such as pelletizing press sheet.The present composition has more preferable effect compared with using the composition of other proportioning preparations of homogeneous raw material, while than traditional Western medicine compound compared to also with close or more preferable effect.
Description
Technical field
The present invention relates to health food and medicine field, and in particular to a kind of composition with auxiliary hyperglycemic function and
Its preparation method.
Background technology
Diabetes are a kind of common disease, frequently-occurring disease, can betide any age bracket, and its number of patients is with people's lives water
Flat raising, the aging of population, living-pattern preservation and improving for diagnostic techniques and increase sharply, diabetes mellitus in China is suffered from present
For person's number up to more than 97,000,000, quantity reaches the first in the world.Diabetes turn into a kind of 21 century worldwide epidemic disease.
It is the Chronic Non-Communicable Diseases of the third-largest serious threat human health after tumour, vascular lesion, turns into our times
The public health problem that various countries face jointly.
The etiology and pathogenesis of diabetes is asthenia in origin and asthenia in superficiality.Using deficiency of both qi and yin to be common, according to the etiology and pathogenesis of diabete, with the moon
Void is this, scorching to mark, and with the passing of time, healthy tendency is damaged, yin deficiency affecting yang, it is seen that impairment of both QI and YIN or deficiency in both YIN and YANG for delay.Lesion internal organs with
Lung, stomach (spleen), based on kidney, among three, though having laid particular stress on, but influence each other more, therapy when based on benefiting qi and nourishing yin, and with
Supplemented by clearing heat and promoting fluid is taken stopgap measures, giving consideration to both the incidental and fundamental, benefiting qi and nourishing yin promotes the production of body fluid, and gas Tianjin is unimpeded, and all diseases must subtract.
Ginseng reinforces vital energy, reinforces the spleen to benefit the lung, slaked thirst and help produce saliva in this product;Radix Astragali invigorating qi for strengthening superficies;Balsam pear can let out the six channels excess fire,
Clear heat, improving eyesight, control pyreticosis polydipsia;Dried rhizome of rehmannia clearing heat and cooling blood, nourishing Yin and promoting production of body fluid;Fructus Corni tonifies the liver and kidney, puckery smart prevent prolapse;Root of kudzu vine liver is light,
It is nontoxic, except heat, quench the thirst;Quan Fangzhong is reinforced the spleen to benefit the lung with ginseng, the Radix Astragali, nourishing generate fluid;Balsam pear, dried rhizome of rehmannia clearing heat-fire, nourishing Yin and promoting production of body fluid;
Fructus Corni tonifies the liver and kidney;The root of kudzu vine promotes the production of body fluid to quench thirst;All tastes share and play supplementing qi and nourishing yin altogether, the effect of clearing heat and promoting fluid.
Modern pharmacological research shows:Contain a variety of blood-sugar decreasing actives in ginseng, ginsenoside can significantly improve serum
Insulin, blood glucose is reduced, increase SOD contents, it is horizontal to reduce LPO;To hyperglycaemia with effect is significantly reduced, it drops panaxan
Sugar effect is slightly below insulin, there is obvious dose-effect relationship.The Radix Astragali has oxidation resistance, the cell knot to keeping beta Cell of islet
Structure is complete, maintains normal physiological function important role, so as to ensure that the link work(such as the synthesis of β cells, uelralante
Can be normal;Astragaloside can promote the secretion of diabetes rat insulin, blood glucose be reduced, so as to contribute to the treatment of diabetes;
In addition, the Radix Astragali is also possible to the secretion by stimulating class glucagon peptide 1 (GLP 1), insulin granule in beta Cell of islet is induced
The recovery of activity, increases insulin secretion, so as to prevent the generation of diabetes in a sense.Balsam pear soap in balsam pear
Glycosides and bitter melon protein, not only there is the function of similar insulin, and β cells secrete insulins can be stimulated, correlative study is shown
Its extract has obvious association reaction with insulin receptor, insulin antibody, shows that it is known as common antigen with pancreas islet
Property and bioactivity.Fructus Corni can reduce blood glucose, improve immunity of organism, and Wheat Protein.Rehmanin in the dried rhizome of rehmannia has
Reduce blood glucose effect, and energy Inhibition test hyperglycaemia, moreover it is possible to stimulate the secretion of insulin, Rehmannia glutinosa oligosaccharide can obviously reduce blood
Sugar, it can also reduce G-6-Pase activity.Puerarin has obvious hypoglycemic effect to alloxan hyperglycaemia, can change
Kind sugar tolerance, also has blood sugar reducing function to adrenal gland disposition hyperglycaemia.
In summary, Quan Fangzhong contains ginseng, the Radix Astragali and a variety of saponin(es of balsam pear and Rehmannia glutinosa oligosaccharide, Puerarin isoreactivity
Composition, acted synergistically the effect of reaching auxiliary hyperglycemic jointly by various active composition.
The content of the invention
The primary and foremost purpose of the present invention is to provide a kind of new composition for having auxiliary hyperglycemic function.
To achieve these goals, the composition includes the component of following parts by weight:Ginseng 5-70 parts, Radix Astragali 10-80
Part, balsam pear 300-1500 parts, dried rhizome of rehmannia 5-80 parts, Fructus Corni 5-70 parts, root of kudzu vine 5-80 parts.
As further preferred scheme:Composition of the present invention includes the component of following parts by weight:Ginseng 10-50
Part, Radix Astragali 20-70 parts, balsam pear 500-1200 parts, dried rhizome of rehmannia 10-70 parts, Fructus Corni 10-60 parts, root of kudzu vine 10-70 parts.
As further preferred scheme:Composition of the present invention includes the component of following parts by weight:Ginseng 10-40
Part, Radix Astragali 30-60 parts, balsam pear 700-1200 parts, dried rhizome of rehmannia 20-60 parts, Fructus Corni 20-50 parts, root of kudzu vine 10-50 parts.
A preferred embodiment of the present invention:Composition of the present invention includes the component of following parts by weight:15 parts of ginseng, Huang
30 parts of stilbene, 1000 parts of balsam pear, 30 parts of the dried rhizome of rehmannia, 40 parts of Fructus Corni, 40 parts of the root of kudzu vine.
A preferred embodiment of the present invention:Composition of the present invention includes the component of following parts by weight:20 parts of ginseng, Huang
60 parts of stilbene, 1100 parts of balsam pear, 60 parts of the dried rhizome of rehmannia, 50 parts of Fructus Corni, 50 parts of the root of kudzu vine.
A preferred embodiment of the present invention:Composition of the present invention includes the component of following parts by weight:30 parts of ginseng, Huang
45 parts of stilbene, 900 parts of balsam pear, 45 parts of the dried rhizome of rehmannia, 30 parts of Fructus Corni, 30 parts of the root of kudzu vine.
In a kind of technical scheme of the present invention, present composition preparation method comprises the following steps:By said ratio
Weigh balsam pear squeeze the juice filtering after filtrate concentration, filter residue powder;With ginseng, the Radix Astragali, the dried rhizome of rehmannia, Fructus Corni, root of kudzu vine traditional Chinese medicine of the five flavours, mixing
After crush, or crush after be mixed to get.
In a kind of technical scheme of the present invention, present composition preparation method comprises the following steps:By said ratio
Weigh balsam pear squeeze the juice filtering after filtrate concentration, filter residue powder;Ginseng, the Radix Astragali, the dried rhizome of rehmannia, Fructus Corni, root of kudzu vine traditional Chinese medicine of the five flavours are carried
Concentration powder is taken, is mixed with and forms.
In a kind of technical scheme of the present invention, present composition preparation method comprises the following steps:By said ratio
Weigh balsam pear squeeze the juice filtering after filtrate concentration, filter residue powder;The step of ginseng, the Radix Astragali, the dried rhizome of rehmannia, Fructus Corni, root of kudzu vine traditional Chinese medicine of the five flavours,
The step of preparing ginseng extract, the step of preparing Astragalus Root P.E, the step of preparing dried rhizome of rehmannia extract, prepare Fructus Corni extraction
The step of thing, the step of preparing kudzu root extract and by above-mentioned ginseng extract, Astragalus Root P.E, dried rhizome of rehmannia extract, mountain Zhu
The step of cornel extract, kudzu root extract mixing.
As further preferred scheme:Present composition preparation method comprises the following steps:
(1) balsam pear squeeze the juice filtering after filtrate concentration, filter residue powder;
(2) ginseng, the Radix Astragali, the dried rhizome of rehmannia concentrate powder processed through water extract-alcohol precipitation;
(3) root of kudzu vine, Fructus Corni concentrate powder processed through alcohol extracting;
(4) it is step (1), step (2) and step (3) is well mixed.
It is another object of the present invention to provide a kind of new oral formulations for having auxiliary hyperglycemic function.
To achieve these goals, present invention employs following technical scheme:Ginseng 5-70 parts, Radix Astragali 10-80 parts, balsam pear
300-1500 parts, dried rhizome of rehmannia 5-80 parts, Fructus Corni 5-70 parts, root of kudzu vine 5-80 parts, are mixed together with pharmaceutic adjuvant, make according to a conventional method
It is standby into oral formulations.Hard capsule, soft capsule, tablet, granule, powder, pill, bag are preferably prepared in some versions
One kind in making tea.
As optimal technical scheme, the present composition is made from the following raw materials in parts by weight:Ginseng 10-50 parts,
Radix Astragali 20-70 parts, balsam pear 500-1200 parts, dried rhizome of rehmannia 10-70 parts, Fructus Corni 10-60 parts, root of kudzu vine 10-70 parts, with pharmaceutic adjuvant one
Mixing is played, is prepared into oral formulations according to a conventional method.Be preferably prepared in some versions hard capsule, soft capsule, tablet,
One kind in granule, powder, pill, tea bag.
As optimal technical scheme, the present composition is made from the following raw materials in parts by weight:Ginseng 10-40 parts,
Radix Astragali 30-60 parts, balsam pear 700-1200 parts, dried rhizome of rehmannia 20-60 parts, Fructus Corni 20-50 parts, root of kudzu vine 10-50 parts, with pharmaceutic adjuvant one
Mixing is played, is prepared into oral formulations according to a conventional method.Be preferably prepared in some versions hard capsule, soft capsule, tablet,
One kind in granule, powder, pill, tea bag.
As optimal technical scheme, the present composition is made from the following raw materials in parts by weight:15 parts of ginseng, the Radix Astragali
30 parts, 1000 parts of balsam pear, 30 parts of the dried rhizome of rehmannia, 40 parts of Fructus Corni, 40 parts of the root of kudzu vine, be mixed together with pharmaceutic adjuvant, make according to a conventional method
It is standby into oral formulations.Hard capsule, soft capsule, tablet, granule, powder, pill, bag are preferably prepared in some versions
One kind in making tea.
As optimal technical scheme, the present composition is made from the following raw materials in parts by weight:20 parts of ginseng, the Radix Astragali
60 parts, 1100 parts of balsam pear, 60 parts of the dried rhizome of rehmannia, 50 parts of Fructus Corni, 50 parts of the root of kudzu vine, be mixed together with pharmaceutic adjuvant, make according to a conventional method
It is standby into oral formulations.Hard capsule, soft capsule, tablet, granule, powder, pill, bag are preferably prepared in some versions
One kind in making tea.
As optimal technical scheme, the present composition is made from the following raw materials in parts by weight:30 parts of ginseng, the Radix Astragali
45 parts, 900 parts of balsam pear, 45 parts of the dried rhizome of rehmannia, 30 parts of Fructus Corni, 30 parts of the root of kudzu vine, be mixed together with pharmaceutic adjuvant, make according to a conventional method
It is standby into oral formulations.Hard capsule, soft capsule, tablet, granule, powder, pill, bag are preferably prepared in some versions
One kind in making tea.
As optimal technical scheme, the preparation method of the above-mentioned oral formulations of the present invention comprises the following steps:
(1) balsam pear squeeze the juice filtering after filtrate concentration, filter residue powder;
(2) ginseng, the Radix Astragali, the dried rhizome of rehmannia concentrate powder processed through water extract-alcohol precipitation;
(3) root of kudzu vine, Fructus Corni concentrate powder processed through alcohol extracting;
(4) it is step (1), step (2) and step (3) is well mixed;
(5) mixture that step (4) obtains is mixed with pharmaceutic adjuvant, oral formulations is made according to a conventional method.
Third object of the present invention is to provide a kind of tablet with auxiliary hyperglycemic function.
In order to better illustrate technical scheme, there is provided following technical scheme should not be seen as pair as reference
The limitation of the present invention:
Ginseng 5-70 parts, Radix Astragali 10-80 parts, balsam pear 300-1500 parts, dried rhizome of rehmannia 5-80 parts, Fructus Corni 5-70 parts, root of kudzu vine 5-
80 parts, it is mixed together with pharmaceutic adjuvant, prepares piece agent according to a conventional method.In some embodiments, the tablet is prepared
Pharmaceutic adjuvant preferably comprises microcrystalline cellulose, Aspartame, magnesium stearate.Wherein, as optimal technical scheme:Prepare above-mentioned
The pharmaceutic adjuvant weight proportion of invention tablet is microcrystalline cellulose 1-30 parts, Aspartame 0.1-10 parts, magnesium stearate 1-5 parts.
As optimal technical scheme, the present invention provides following technical scheme:Ginseng 10-50 parts, Radix Astragali 20-70 parts, balsam pear
500-1200 parts, dried rhizome of rehmannia 10-70 parts, Fructus Corni 10-60 parts, root of kudzu vine 10-70 parts.It is mixed together with pharmaceutic adjuvant, routinely side
Method prepares piece agent.In some embodiments, the pharmaceutic adjuvant for preparing the tablet preferably comprises microcrystalline cellulose, A Siba
Sweet tea, magnesium stearate.Wherein, as optimal technical scheme:The pharmaceutic adjuvant weight proportion for preparing the invention described above tablet is crystallite
Cellulose 5-20 parts, Aspartame 0.2-8 parts, magnesium stearate 0.2-3 parts.
As optimal technical scheme, Tablets provide following technical scheme:Ginseng 10-40 parts, Radix Astragali 30-60 parts,
Balsam pear 700-1200 parts, dried rhizome of rehmannia 20-60 parts, Fructus Corni 20-50 parts, root of kudzu vine 10-50 parts.It is mixed together with pharmaceutic adjuvant, by normal
Rule method prepares piece agent.In some embodiments, prepare the tablet pharmaceutic adjuvant preferably comprise microcrystalline cellulose, Ah
This Ba Tian, magnesium stearate.Wherein, as optimal technical scheme:Prepare the invention described above tablet pharmaceutic adjuvant weight proportion be
Microcrystalline cellulose 10-15 parts, Aspartame 0.5-3 parts, magnesium stearate 0.3-2 parts.
As optimal technical scheme, Tablets provide following technical scheme:15 parts of ginseng, 30 parts of the Radix Astragali, balsam pear
1000 parts, 30 parts of the dried rhizome of rehmannia, 40 parts of Fructus Corni, 40 parts of the root of kudzu vine.It is mixed together with pharmaceutic adjuvant, prepares piece agent according to a conventional method.
In some embodiments, the pharmaceutic adjuvant for preparing the tablet preferably comprises microcrystalline cellulose, Aspartame, magnesium stearate.
Wherein, as optimal technical scheme:Prepare the invention described above tablet pharmaceutic adjuvant weight proportion for 15 parts of microcrystalline cellulose, Ah
0.6 part of this Ba Tian, 0.4 part of magnesium stearate.
As optimal technical scheme, Tablets can use following technical scheme:20 parts of ginseng, 60 parts of the Radix Astragali, hardship
1100 parts of melon, 60 parts of the dried rhizome of rehmannia, 50 parts of Fructus Corni, 50 parts of the root of kudzu vine.It is mixed together, is prepared according to a conventional method in flakes with pharmaceutic adjuvant
Agent.In some embodiments, when preparing the pharmaceutic adjuvant of the tablet comprising microcrystalline cellulose, Aspartame, magnesium stearate
Superior technique effect can be obtained.Wherein, auxiliary material weight proportion is 15 parts of microcrystalline cellulose, 0.6 part of Aspartame, tristearin
Sour this technical scheme effect of 0.4 part of magnesium is more excellent.
Alternatively, Tablets can also use following technical scheme:30 parts of ginseng, 45 parts of the Radix Astragali,
900 parts of balsam pear, 45 parts of the dried rhizome of rehmannia, 30 parts of Fructus Corni, 30 parts of the root of kudzu vine.It is mixed together, is prepared according to a conventional method in flakes with pharmaceutic adjuvant
Agent.In some embodiments, the pharmaceutic adjuvant for preparing the tablet preferably comprises microcrystalline cellulose, Aspartame, stearic acid
Magnesium.Wherein, as optimal technical scheme:The pharmaceutic adjuvant weight proportion for preparing the invention described above tablet is microcrystalline cellulose 15
Part, 0.6 part of Aspartame, 0.4 part of magnesium stearate.
The preparation method of the above-mentioned tablet of the present invention comprises the following steps:
(1) balsam pear squeeze the juice filtering after filtrate concentration, filter residue powder;
(2) ginseng, the Radix Astragali, the dried rhizome of rehmannia concentrate powder processed through water extract-alcohol precipitation;
(3) root of kudzu vine, Fructus Corni concentrate powder processed through alcohol extracting;
(4) it is step (1), step (2) and step (3) is well mixed.
(5) by mixture obtained by microcrystalline cellulose, Aspartame and step (4) through pelletizing, drying, stiffened fatty acid magnesium pressure
Piece, obtain tablet.
As more preferably technical scheme:The preparation method for preparing the invention described above tablet comprises the following steps:
(1) weigh balsam pear to squeeze the juice, filter, filtrate keeps negative pressure to be concentrated under reduced pressure into relative density about in more than 0.08Mpa
1.30-1.40 thick paste is standby;Ultramicro grinding is fine powder after filter residue low temperature drying.
(2) ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed to put in extractor, adds 5-10 times of water refluxing extraction 1-3 times, each 0.5-2h, mistake
Filter, merging filtrate, concentration, adding ethanol makes alcohol content reach 40-60%, 10 DEG C of stand at low temperature 8-36h, Aspirate supernatant mistake
Filter, be concentrated under reduced pressure into medicinal extract, it is spray-dried that fine powder is made.
(3) weigh the root of kudzu vine, Fructus Corni is put in extractor, add 4-8 times measure 40%-70% alcohol refluxs extract 1-3 times, often
Secondary extraction 0.5-3h, filtering, merging filtrate, ethanol is reclaimed, is concentrated into medicinal extract, it is spray-dried into fine powder.
(4) it is step (1) (2) (3) is well mixed.
(5) by mixture obtained by microcrystalline cellulose, Aspartame and step (4) through 30-80% alcohol granulations, 20-80 DEG C
Dry, stiffened fatty acid magnesium tabletting obtains tablet.
Fourth object of the present invention is that provide a kind of composition of the present invention has auxiliary hyperglycemic function in preparation
Medicine or health products in application, preferably prepare prevention and treatment diabetes medicine or health products in application.
The 5th purpose of the present invention is that provide a kind of tablet of the present invention has auxiliary hyperglycemic function in preparation
Application in medicine or health products, the preferably application in the medicine or health products for preparing prevention and treatment diabetes.
Composition of the present invention shows to significantly reduce on an empty stomach and postprandial plasma glucose level, while to high blood through zoopery
The cardinal symptoms such as sugared crowd eats more, more drink, diuresis, fatigue and weaks have a better role.
Specific embodiment
Following is in conjunction with specific embodiments and experimental example, the present invention to be expanded on further.But these embodiments and experimental example are only
It is limited to illustrate rather than for limiting the scope of the present invention.
First, embodiment is prepared
Embodiment 1
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 2
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 3
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 4
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 5
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 6
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 7
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 8
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 9
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 10
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 11
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 12
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia, the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, mixing, crush, cross 80 mesh sieves, obtaining ginseng, Huang
Stilbene, the dried rhizome of rehmannia, the root of kudzu vine, Fructus Corni composition.
Embodiment 13
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 14
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 15
Prescription:
Preparation method:
After balsam pear is weighed up by recipe quantity, cleaning, remove seed, squeeze the juice, filter, filtrate keeps negative pressure to be depressurized in more than 0.08MPa
The thick paste of relative density about 1.30~1.40 is concentrated into, spray-dried, crushing, obtains balsam pear dried cream powder after crossing 80 mesh sieves;Filter residue
Ultramicro grinding obtains Bitter Melon P.E after low temperature drying.
After ginseng, the Radix Astragali, the dried rhizome of rehmannia are weighed up by recipe quantity, respectively plus 10 times of amounts, 8 times of amount water (m/m) refluxing extractions are secondary, often
Secondary two hours, merge extract solution, filtering, filtrate decompression is concentrated into suitable density about 1.25~1.35, and adding ethanol makes alcohol content
Reach 70%, 10 DEG C or so stand at low temperature 24 hours, Aspirate supernatant filtering, filtrate keeps negative pressure to be depressurized in more than 0.06Mpa
Recovery ethanol is simultaneously concentrated into relative density about 1.10~1.20, spray drying, crushes, crosses 80 mesh sieves, obtaining the ginseng Radix Astragali dried rhizome of rehmannia and carry
Take thing.
After the root of kudzu vine, Fructus Corni are weighed up by recipe quantity, respectively plus 8 times of amounts, 6 times of amount 60% ethanol (v/m) refluxing extractions are secondary,
Two hours every time, merge extract solution, filtering, ethanol is recovered under reduced pressure in more than 0.06Mpa in filtrate holding negative pressure and is concentrated into phase
To density about 1.10~1.20, spray-dried, crushing, 80 mesh sieves are crossed, obtain root of kudzu vine cornel extractive.
Balsam pear dried cream powder, Bitter Melon P.E, ginseng Radix Astragali cornel extractive and root of kudzu vine cornel extractive are mixed equal
It is even to produce the present composition.
Embodiment 16
The present composition that embodiment 15 obtains is pulverized and sieved, adds 100g microcrystalline celluloses and 4g magnesium stearates, is mixed
It is bonded to uniformly, pours into capsule, capsule is made.
Embodiment 17
The present composition that embodiment 15 obtains is pulverized and sieved, adds 16.5g microcrystalline celluloses, 0.64g Aspartames
With 0.4g magnesium stearates, mix to uniform, tabletting, tablet is made.
Embodiment 18
The present composition that embodiment 15 obtains is pulverized and sieved, adds 6g dextrin, is mixed to uniform, granulation is made
Granula.
Embodiment 19
The present composition that embodiment 15 obtains is pulverized and sieved, adds 10g starch and 5g honey, is mixed to uniform, system
Ball, pill is made.
Embodiment 20
The present composition that embodiment 15 obtains is pulverized and sieved, mixes to uniform, divides pouch-packaged, powder is made.
Embodiment 21
24.8g microcrystalline celluloses and 0.96g Aspartames are weighed, adds the present composition that embodiment 1 obtains, mixing
Uniformly, add ethanol and suitable softwood is made, pelletize, then cross 14 mesh sieve whole grains, 0.6g magnesium stearates are added, in automatic tableting press
Upper tabletting, is packed after the assay was approved, obtains tablet.
Embodiment 22
22.5g microcrystalline celluloses and 3.21g Aspartames are weighed, adds the present composition that embodiment 1 obtains, mixing
Uniformly, add ethanol and suitable softwood is made, pelletize, then cross 14 mesh sieve whole grains, 0.6g magnesium stearates are added, in automatic tableting press
Upper tabletting, is packed after the assay was approved, obtains tablet.
Embodiment 23
21g microcrystalline celluloses and 0.75g Aspartames are weighed, adds the present composition that embodiment 1 obtains, mixing is equal
It is even, add ethanol and suitable softwood is made, pelletize, then cross 14 mesh sieve whole grains, 0.3g magnesium stearates are added, on automatic tableting press
Tabletting, pack after the assay was approved, obtain tablet.
Embodiment 24
21.7g microcrystalline celluloses and 1.18g Aspartames are weighed, adds the present composition that embodiment 4 obtains, mixing
Uniformly, add ethanol and suitable softwood is made, pelletize, then cross 14 mesh sieve whole grains, 1.54g magnesium stearates are added, in automatic tabletting
Tabletting on machine, is packed after the assay was approved, obtains tablet.
Embodiment 25
22.3g microcrystalline celluloses and 0.5g Aspartames are weighed, adds the present composition that embodiment 4 obtains, mixing
Uniformly, add ethanol and suitable softwood is made, pelletize, then cross 14 mesh sieve whole grains, 0.84g magnesium stearates are added, in automatic tabletting
Tabletting on machine, is packed after the assay was approved, obtains tablet.
Embodiment 26
21.4g microcrystalline celluloses and 0.62g Aspartames are weighed, adds the present composition that embodiment 4 obtains, mixing
Uniformly, add ethanol and suitable softwood is made, pelletize, then cross 14 mesh sieve whole grains, 2.52g magnesium stearates are added, in automatic tabletting
Tabletting on machine, is packed after the assay was approved, obtains tablet.
Embodiment 27
13.8g microcrystalline celluloses and 0.58g Aspartames are weighed, adds the present composition that embodiment 7 obtains, mixing
Uniformly, add ethanol and suitable softwood is made, pelletize, then cross 14 mesh sieve whole grains, 1.4g magnesium stearates are added, in automatic tableting press
Upper tabletting, is packed after the assay was approved, obtains tablet.
Embodiment 28
20g microcrystalline celluloses and 0.9g Aspartames are weighed, adds the present composition that embodiment 2 obtains, mixing is equal
It is even, add ethanol and suitable softwood is made, pelletize, then cross 14 mesh sieve whole grains, 0.6 magnesium stearate is added, on automatic tableting press
Tabletting, pack after the assay was approved, obtain tablet.
Embodiment 29
10.9g microcrystalline celluloses and 0.66g Aspartames are weighed, adds the present composition that embodiment 11 obtains, is mixed
Close uniform, add ethanol and suitable softwood is made, pelletize, then cross 14 mesh sieve whole grains, add 0.77g magnesium stearates, from dynamic pressure
Tabletting on piece machine, is packed after the assay was approved, obtains tablet.
Part II toxicity and pharmacodynamic experiment
Test example 1, toxicological experiment
1st, acute toxicity test in mice:Test specimen:Capsule prepared by embodiment 16;From cleaning grade Kunming mouse
20,18-22 grams of body weight, male and female half and half, tested by MTD methods.Maximum dose level be 15000mg/kgbw (using distilled water as
Solvent, similarly hereinafter), using disposable gavage in isometric administration by gavage (0.2ml/10gbw) 24 hours, Continuous Observation two weeks.Note
Record poisoning manifestations and death condition.
2nd, rat acute toxicity test:Test specimen:Tablet made from embodiment 28;From cleaning grade SD rats 20,
180-220 grams of body weight, male and female half and half, tested by MTD methods.Maximum dose level is 15000mg/kgbw, is filled using isometric
Disposable gavage in stomach method (2ml/10gbw) 24 hours, Continuous Observation two weeks.Record poisoning manifestations and death condition.
3rd, genetic toxicity test:
Test specimen:Tablet made from embodiment 23
(1) Salmonella reversion test:This experiment uses flat board incorporation methods, is divided to plus with being not added with two kinds of S9 mixed liquors.Dosage is respectively
0.005th, 0.025,0.250,1.000,5.000mg/ wares, separately set blank control, solvent control distilled water, 0.1ml/ wares.Sun
Property control group using 2-AF20 μ g/ wares, 2,4,7-TNFonelug/ wares, NaN32.5 μ g/ wares, the μ g/ wares of mitomycin C 4.0,1,
The μ g/ wares of 8- dihydroxy anthraquinones 50, each dosage group make three plates, and repetition is done twice.Strain is T A97 (a), T A98, T
Tetra- plants of A100, T A102 bacterium.
(2) PCEMNR micronucleus (MNPCE) is tested:From cleaning grade Kunming mouse 50, body weight
25-30 grams, it is randomly divided into five groups, every group 10, male and female half and half;If three dosage groups:2500th, 5000,10000mg/kg bodies
Weight, while sets negative control group (distilled water) and positive controls (CP40mg/kg), and each group is spaced 24 hours twice to sample,
Bone marrow of sternum film-making was taken to 6 hours after sample using isometric administration by gavage (0.2ml/10gbw) for the second time, every animal counts
1000 polychromatic erythrocytes, calculate wherein microkernel incidence.
(3) mouse inbred strain:From cleaning grade Male Kunming strain mice 25,30-35 grams of body weight, it is randomly divided into
Five groups, every group five;If three dosage groups:2500th, 5000,10000mg/kg body weight, while set negative control group (distilled water)
It is continuous orally to give sample 5 days with positive controls (CP40mg/kg).Animal is put to death to sample meter within the 35th day, take bilateral epididymal from first
Film-making, every animal count 1000 sperms, calculate abnormal rate.
(4) 30 days feeding trials:From cleaning grade SD rats 80, body weight 60-80g, four groups, every group 20 are randomly divided into
Only.Male and female half and half, single cage raising.Tested material sets three test doses, respectively 8.0g/kg body weight, 4.0g/kg body weight,
2.0g/kg body weight (100 times of high dose equivalent to recommended amounts), tested material is incorporated into basal feed respectively and is fed with, continuously
30 days.Rat daily inleting appetite calculates by the 10% of its body weight, and contained tested material is respectively 8.0%, 4.0%, 2.0% in feed.
Negative control group is fed with basal feed, the equal ad lib of each group animal and drinking-water during nursing, claims mouse body weight weekly and records feeding
Expect consumption once, experiment latter stage adopts tail blood and carries out hematology and biochemical analysis.Observation index have body weight, food utilization,
Hematological examination (being determined using blood counting instrument), biochemical analysis are (raw using corresponding reagent box and automatically after separation serum
Change analysis-e/or determining), experiment latter stage puts to death rat, and solution takes liver,spleen,kidney, testis (ovary) is weighed, and calculates organ coefficient, so
Histopathological examination (paraffin section) is carried out to liver,kidney,spleen, stomach, intestines, testis (ovary) afterwards.
It is above-mentioned test result indicates that, the present composition is all higher than 15000mg/ to the MTD of the large and small mouse of two kinds of sexes
Kgbw, illustrate product nontoxicity;Three mutagenicity test results are negative;30 days feeding trial indices of rat are without bright
It is aobvious abnormal.
The present composition of test example 2 is tested auxiliary hyperglycemic action function
This experiment uses the tablet that sample is prepared for embodiment 25.
Kunming mouse is chosen, male Body Weight 24-26g, is provided by Hebei province's Experimental Animal Center.Animal quality certification number:
SCXK (Ji) 2003-1-003.
Dosage choice:Product human body recommended amounts are 4.8g/ days/60kgbw, and the dose,equivalent of mouse pushes away equivalent to human body
10 times of the amount of recommending, i.e., daily ingestion of 0.8g/kgbw be low dosage, then respectively set a metering group by 2 times of low dosage and 3 times,
That is 1.6/kgbw (middle dosage) and 2.4g/kgbw (high dose), control group to distilled water, daily isometric gavage once,
After giving tested material 30 days, indices are determined.
Experimental method:(1) to the influence of normal mouse fasting blood-glucose
It is grouped by fasting 3h mouse blood sugar value, it is control group to select 1 at random, and 1 is high dose group, and every group 10 dynamic
Thing.Continuously give tested material 30 days, fasting blood sugar is surveyed after last gavage 0.5h.
(2) to the influence of alloxan diabetes model mice fasting blood-glucose
43mg/kgbw alloxans are given through tail vein after animal fasting 24h, the 7th day fasting 4h, survey blood glucose value, choosing
The mouse for taking blood glucose value 10-25mmol/L is hyperglycemia model mouse.Four groups are randomly divided into, wherein 1 model control group,
3 dosage groups, every group of equal 11 mouse (control group is to distilled water).Each dosage group continuously gives tested material 30 days, is filled in last
Fasting blood sugar is surveyed after stomach 0.5h.
(3) to the influence of alloxan diabetes model mice sugar tolerance
43mg/kgbw alloxans are given through tail vein after animal fasting 24h, the 7th day fasting 4h, survey blood glucose value, choosing
The mouse for taking blood glucose value 10-25mmol/L is hyperglycemia model mouse.Four groups are randomly divided into, wherein 1 model control group,
3 dosage groups, every group of equal 11 mouse (control group is to distilled water).Each dosage group continuously gives tested material 30 days, is filled in last
Oral administration of glucose 2.0g/kgbw after stomach 15-20min, measure 0,0.5,2h blood glucose value.
Result is examined using t and carries out statistical disposition.
Influence to hyperglycemia model mouse weight is shown in Table 1.
The each group mouse original body mass of table 1, mid-term body weight, latter stage body weight (g)
Dosage (g/kgbw) | Animal (only) | Original body mass | Animal (only) | Mid-term body weight | Animal (only) | Terminate body weight |
Model comparison | 11 | 26.4±0.96 | 11 | 28.1±1.8 | 11 | 29.9±2.4 |
Low (0.8) | 11 | 26.5±1.27 | 11 | 28.3±1.8 | 11 | 30.0±3.5 |
In (1.6) | 11 | 26.3±1.44 | 11 | 28.4±1.5 | 11 | 30.2±3.4 |
High (2.4) | 11 | 26.7±0.85 | 11 | 28.2±1.1 | 11 | 29.7±2.9 |
As can be seen from Table 1, the product of orally administration mouse various dose 30 days, the body weight of each experimental mice is with compareing
Group is compared to there was no significant difference (P > 0.05).
Influence to normal mouse fasting blood-glucose:It is shown in Table 2.
Influence of the table 2 to normal mouse fasting blood-glucose
As can be seen from Table 2, the product of the normal high dose of orally administration 30 days, before the fasting blood-glucose change and administration of mouse
Compare that there was no significant difference (P > 0.05).
Influence to hyperglycaemia mice serum fasting blood-glucose:It is shown in Table 3
Influence of the table 3 to hyperglycaemia mouse fasting blood-glucose
As can be seen from Table 3, the product of orally administration mouse various dose 30 days, the fasting blood sugar of high dose group mouse
Significantly lower than the fasting blood sugar (P < 0.05) of model control group.
Influence to hyperglycemia model glucose tolerance in mice:It is shown in Table 4
Influence of the table 4 to hyperglycemia model glucose tolerance in mice
With model control group ratio * * P < 0.01*P < 0.05
From table 4, the product of orally administration mouse various dose 30 days, to each dosage group mouse 2.0g/kgbw Portugals
Grape sugar, the middle and high dosage group of 0.5h and 2h blood glucose values are substantially less than model control group (P < 0.05, P < 0.01).
Influence to hyperglycaemia glucose tolerance in mice:It is shown in Table 5
Influence of the table 5 to hyperglycemia model mouse TG-AUC
As can be seen from Table 5, the product of orally administration mouse various dose 30 days, can from sugar tolerance experimental result
Go out, middle dose group and high dose group TG-AUC are obvious compared with control group to be reduced, difference be respectively provided with conspicuousness (P < 0.05,
P < 0.01).
The function of reducing blood sugar human experiment experiment of the present invention of test example 3
Experiment uses the tablet that sample is prepared for embodiment 28.
1st, subject selects:Selection state of an illness after diet control or OHA treatment is relatively stable, it is not necessary to more dressing
Article kind and dosage, only take the adult type ii diabetes patient of maintenance dose, fasting blood-glucose >=7.8mmol/L (140mg/dl) or
2h-plasma glucose >=11.1mmol/L (200mg/dl);Also 7.8mmol/L >=fasting blood-glucose >=6.7mmol/L may be selected
(120mg/dl) or 11.1mmol/L (200mg/dl) >=2h-plasma glucose >=7.8mmol/L hyperglycemia population.Subject without
The complication of the main organs such as the heart, liver, kidney, hepatic and renal function is good, and nothing takes glucocorticoid and other influences hypoglycemic medicament history.
Eliminator's standard:Type i diabetes patient;Age is in under-18s or over-65s person, pregnant or women breast-feeding their children;
There are the complication such as severe cardiac, liver, kidney, or be associated with other severe primary diseases, mental patient;Loner, it can not sentence
Determine the infull person of effect or data.
2nd, test-meal method:100 subjects, two groups are randomly divided into, original takes hypoglycemic medicine kind and dosage is constant, test-meal
Tablet prepared by group plus food embodiment 28,3 times a day, 2 tablets once.Control group takes placebo, the same test-meal group of dose, it is desirable to
Examination trencherman adheres to diet control for a long time, is fed by different labor intensity and build.Each group is designed using own control, is between two groups
Control design between group.
3rd, observation index:Indices in test-meal test start and at the end of each test once, test-meal the 15th day plus survey empty
Abdomen blood glucose is once.
Efficiency observation:Detailed medical history-taking, understand patient diet's situation, activity, observe main clinic symptoms:It is more
Food, more drink, diuresis, fatigue and weaks etc..Integration is counted before and after test-meal by symptom weight (severe 3 is divided, moderate 2 is divided, mild 1 is divided)
Value, and (each 2 points of symptom improvement is effective, and it is effective to improve 1 point) is improved with regard to its cardinal symptom, observe symptom improvement rate.Monitoring
Fasting blood-glucose and postprandial 2 hours blood glucose, glucose in urine urine ketone bodies and blood fat.
Experimental group takes tested material, and control group takes identical character without effect placebo.3 tablets each time, 3 times a day, continuously
30 days, subject cut out during experiment
Safety observations:Including blood, urine, feces routine inspection;Biochemical Indexes;Abdominal B-scan ultrasonography, electrocardiogram, x-ray chest are saturating
Depending on.
Effect criterion:Cardinal symptom is obviously improved, and it is effective that blood glucose declines >=10% before relatively treating;Cardinal symptom without
Be obviously improved, blood glucose drop to reach above-mentioned standard be considered as it is invalid.
4th, experimental result:
General information:100 are observed altogether, test-meal group male 25, women 25, the age is minimum 37 years old, and the oldest 65
It is year, average 54.18 years old, average course of disease 5.94;Control group male 16, women 34, the age is minimum 35 years old, and the oldest 65
It is year, average 54.70 years old, average course of disease 6.01.
Ordinary circumstance compares before two groups of observations:
Ordinary circumstance compares (X ± SD) before table 1 is observed
Table 2 tries trencherman and takes hypoglycemic medicine situation
Group | Number of cases | Sulfonylureas | Biguanides | Sulfonylurea+biguanides | Do not take |
Test-meal group | 50 | 19 | 11 | 15 | 5 |
Control group | 50 | 18 | 12 | 17 | 3 |
Table 1, table 2 are visible, indices no significant difference before two groups of test-meals, have comparativity.
Function of reducing blood sugar:On an empty stomach and postprandial blood sugar compares:
Fasting blood-glucose and postprandial 2 hours blood glucose compare (mmol/L, X ± SD) before and after 3 two groups of test-meals of table
Own control * P < 0.05;#P < 0.05 are compareed between 0.01 group of * P <
After one month, experimental group fasting blood-glucose averagely declines 1.09mmol/L, and postprandial 2 hours blood glucose averagely declines
1.47mmol/L;Control group fasting blood-glucose and postprandial 2 hours blood glucose decline unobvious.
Fasting blood-glucose, glucose in urine, urine ketone bodies compare:
Fasting blood-glucose and the change of glucose in urine urine ketone bodies are compared (X ± SD) after in before the implementation of table 4
Project | Number of cases | Before test-meal | In test-meal | Preceding middle difference | Before after examination | Front and rear difference |
Blood glucose (mmol/L) | 50 | 9.76±2.75 | 9.23±2.24 | -0.53±1.47 | 8.67±2.24 | -1.09±1.66** |
(50) | (9.17±2.25) | (10.03±2.56) | (+0.85±1.71) | (9.39±2.49) | (+0.21±1.55)# | |
Glucose in urine (integrated value) | 18 | 1.25±1.02 | 0.94±1.10 | 0.31±1.33 | ||
(16) | (1.56±1.06) | (1.75±1.11) | (+0.19±1.17) | |||
Urine ketone bodies | 50 | — | — | 13.83±3.94 | ||
(50) | (—) | (—) |
() control group own control * * P < 0.01
Effect of lowering blood sugar compares:
The blood glucose value effect of table 6 counts
Packet | Effectively | It is invalid | Total effective rate (%) | |
Experimental group | Number of cases | 32 | 18 | 32 |
Effect rate (%) | 64.00 | 36.00 | 64.00 | |
Control group | Number of cases | 12 | 38 | 12 |
Effect rate (%) | 24.00 | 76.00 | 24.00 |
Through X2Experiment, two groups of total effective rate significant differences, #P < 0.05.
Symptom improves situation:
The cardinal symptom of table 7 improves situation
Symptom | Number of cases | It is effective | Effectively | It is invalid | Improvement rate (%) |
More foods | 11 | 0 | 7 | 4 | 63.64 |
(17) | (0) | (6) | (11) | (35.29) | |
More drinks | 14 | 0 | 7 | 7 | 50.00 |
(17) | (1) | (6) | (10) | (41.18) | |
Diuresis | 15 | 1 | 7 | 7 | 53.33 |
(15) | (0) | (6) | (9) | (40.00) | |
Lassitude and weak | 23 | 0 | 12 | 11 | 52.17 |
(22) | (0) | (9) | (13) | (40.91) |
() control group
In terms of each cardinal symptom improvement, experimental group is superior to control group.
Clinical symptoms integration statistics:
The clinical symptoms of table 8 integration statistics (X ± SD)
Packet | Number of cases | Before test-meal | In test-meal | After test-meal |
Experimental group | 50 | 7.24±4.90 | 6.36±4.89*** | 5.64±4.89*** |
Control group | 50 | 7.08±4.84 | 6.04±4.54*** | 5.80±4.50*** |
Own control * * * P < 0.001
Experimental group and control group play the role of to improve clinical symptoms.
Blood Lipid situation:
Blood Lipid compares (X ± SD) before and after the test-meal of table 9
Experimental group has no significant effect with control group to blood fat items.
Blood safety index observing:
The change of blood safety index is compared (X ± SD) before and after the test-meal of table 10
Before and after two groups of test-meals, blood testing and urine, feces routine indices are in normal range (NR).
Chest X-rays, electrocardiogram, ultrasound diagnosis:Subject is in normal range (NR).
5th, conclusion:This product have it is more obvious reduce on an empty stomach and the effect of postprandial blood sugar, under experimental group fasting blood sugar
1.09 ± 1.66mmol/L drops, and postprandial blood sugar declines 1.47 ± 1.93mmol/L, wherein effective 32, total effective rate
64.00%;Control group fasting blood-glucose and postprandial blood sugar decline unobvious, wherein effective 12, total effective rate 24.00%, two groups
Compare that there were significant differences, illustrate that this product has certain effect of lowering blood sugar.The product tries hyperglycaemia trencherman and eats more, drink more, be more
The cardinal symptoms such as urine, fatigue and weak, have a better role.After test-meal this product, hemoglobin, red blood cell, leucocyte, serum
Total protein, albumin, glutamic-pyruvic transaminase, glutamic-oxalacetic transaminease, inosine, urea, routine urinalysis, just the Index for examination such as conventional items exists
Normal range (NR), illustrate that this product has no adverse effects to examination trencherman's health.This product during test-meal do not observe allergy and
Other adverse reactions.
It should be understood that after the above-mentioned instruction content of the present invention has been read, those skilled in the art can make to the present invention
Various changes or modification, these equivalents equally fall within the application appended claims limited range.
Claims (13)
1. a kind of composition, it is characterised in that include the component of following parts by weight:
5~70 parts of ginseng, 10~80 parts of the Radix Astragali
300~1500 parts of balsam pear, 5~80 parts of the dried rhizome of rehmannia
5~70 parts of Fructus Corni, 5~80 parts of the root of kudzu vine
。
2. composition according to claim 1, it is characterised in that include the component of following parts by weight:
10~50 parts of ginseng, 20~70 parts of the Radix Astragali
500~1200 parts of balsam pear, 10~70 parts of the dried rhizome of rehmannia
10~60 parts of Fructus Corni, 10~70 parts of the root of kudzu vine
。
3. composition according to claim 2, it is characterised in that include the component of following parts by weight:
10~40 parts of ginseng, 30~60 parts of the Radix Astragali
700~1200 parts of balsam pear, 20~60 parts of the dried rhizome of rehmannia
20~50 parts of Fructus Corni, 10~50 parts of the root of kudzu vine
。
4. composition according to claim 3, it is characterised in that include the component of following parts by weight:
15 parts of ginseng, 30 parts of the Radix Astragali, 1000 parts of balsam pear, 30 parts of the dried rhizome of rehmannia, 40 parts of Fructus Corni, 40 parts of the root of kudzu vine.
5. composition according to claim 3, it is characterised in that include the component of following parts by weight:
20 parts of ginseng, 60 parts of the Radix Astragali, 1100 parts of balsam pear, 60 parts of the dried rhizome of rehmannia, 50 parts of Fructus Corni, 50 parts of the root of kudzu vine.
6. composition according to claim 3, it is characterised in that include the component of following parts by weight:
30 parts of ginseng, 45 parts of the Radix Astragali, 900 parts of balsam pear, 45 parts of the dried rhizome of rehmannia, 30 parts of Fructus Corni, 30 parts of the root of kudzu vine.
7. the preparation method of any compositions of claim 1-6, it is characterised in that weigh balsam pear by proportioning and squeeze the juice after filtering
Filtrate concentration, filter residue powder, with ginseng, the Radix Astragali, the dried rhizome of rehmannia, Fructus Corni, root of kudzu vine traditional Chinese medicine of the five flavours, are crushed after mixing, or are mixed after crushing
Close.
8. the preparation method of any compositions of claim 1-6, it is characterised in that weigh balsam pear by proportioning and squeeze the juice after filtering
Filtrate concentration, filter residue powder, ginseng, the Radix Astragali, the dried rhizome of rehmannia, Fructus Corni, root of kudzu vine traditional Chinese medicine of the five flavours are carried out extracting concentration powder, are mixed with
Form.
9. the preparation method of composition according to claim 8, it is characterised in that by proportioning weigh balsam pear squeeze the juice filtering after filter
Liquid concentration, filter residue powder, ginseng, the Radix Astragali, the dried rhizome of rehmannia concentrate powder processed through water extract-alcohol precipitation, and the root of kudzu vine, Fructus Corni concentrate powder processed through alcohol extracting, mixed
Conjunction is prepared.
10. include the oral formulations of any compositions of claim 1-6.
11. oral formulations according to claim 10, it is characterised in that the oral formulations are selected from hard capsule, flexible glue
Wafer, tablet, granule, powder, pill, one kind of tea bag.
12. oral formulations according to claim 11, it is characterised in that the preparation is tablet.
13. any compositions of claim 1-6 answering in medicine or health products with auxiliary hyperglycemic effect is prepared
With.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710820373.7A CN107837309B (en) | 2017-09-12 | 2017-09-12 | Composition with auxiliary blood sugar reducing function and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710820373.7A CN107837309B (en) | 2017-09-12 | 2017-09-12 | Composition with auxiliary blood sugar reducing function and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107837309A true CN107837309A (en) | 2018-03-27 |
CN107837309B CN107837309B (en) | 2020-05-12 |
Family
ID=61683277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710820373.7A Active CN107837309B (en) | 2017-09-12 | 2017-09-12 | Composition with auxiliary blood sugar reducing function and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107837309B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1537601A (en) * | 2003-04-17 | 2004-10-20 | 武汉宇泰科技有限公司 | Health-care food for diabetes mellitus patient |
CN102204990A (en) * | 2011-05-18 | 2011-10-05 | 南京中医药大学 | Couplet medicine extract for reducing sugar content and preventing diabetic angiopathy and preparation method thereof |
CN105878558A (en) * | 2014-12-25 | 2016-08-24 | 王楠 | Folk prescription for treating diabetes mellitus |
-
2017
- 2017-09-12 CN CN201710820373.7A patent/CN107837309B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1537601A (en) * | 2003-04-17 | 2004-10-20 | 武汉宇泰科技有限公司 | Health-care food for diabetes mellitus patient |
CN102204990A (en) * | 2011-05-18 | 2011-10-05 | 南京中医药大学 | Couplet medicine extract for reducing sugar content and preventing diabetic angiopathy and preparation method thereof |
CN105878558A (en) * | 2014-12-25 | 2016-08-24 | 王楠 | Folk prescription for treating diabetes mellitus |
Also Published As
Publication number | Publication date |
---|---|
CN107837309B (en) | 2020-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106606529A (en) | Composition with auxiliary blood sugar reduction efficacy, and preparation method and application thereof | |
CN102090630B (en) | Health-care product for enhancing antioxidation of human bodies and preparation method thereof | |
CN106692297A (en) | Composition for assistedly decreasing blood sugar, and preparation method and application thereof | |
CN101658597B (en) | Health care step-down tea and preparation method thereof | |
CN102349941A (en) | Traditional Chinese medicine composition for relieving fatigue and improving anoxia endurance and preparation method thereof | |
CN105079089A (en) | Preparation method of kudzuvine root and bitter gourd health-care food assisting in reducing blood glucose | |
CN102058099B (en) | Health care food for losing weight | |
CN105725187A (en) | Blood sugar reducing composition and application in preparation of foods and health-care foods | |
CN102228551B (en) | Chinese medicinal composition for preventing and treating injury of gastric mucosa and preparation method thereof | |
CN101804123B (en) | Plant raw material composition with anti-fatigue effect, preparation method, application and product thereof | |
CN102488202A (en) | Medicinal composition for treating diabetes and preparation method thereof | |
CN109157584A (en) | A kind of composition and its preparation method and application with auxiliary lipid-lowering function | |
CN100428951C (en) | Yuanhe tablet and process for preparing the same | |
CN101336965A (en) | Chinese prepared medicine for improving sugar tolerance and reducing blood sugar and preparation method thereof | |
CN104664011B (en) | A kind of composition with clearing healthcare function and preparation method thereof | |
CN101829272B (en) | Traditional Chinese medicine composition for treating diabetes mellitus and preparation method thereof | |
CN115137770A (en) | Preparation method of traditional Chinese medicine product with efficacy of reducing blood fat and blood pressure | |
CN101564511B (en) | Natural protein product for treating diabetes and manufacture method | |
CN100531783C (en) | Health-care food for reducing blood sugar on the assistant role and its preparing process | |
CN104127816B (en) | A kind of pharmaceutical composition for treating diabetes and its production and use | |
CN107837309A (en) | A kind of composition with auxiliary hyperglycemic function and preparation method thereof | |
CN109620913B (en) | Composition for preventing and/or treating obesity and hyperglycemia | |
CN104173734B (en) | A kind of pharmaceutical composition for treating IGR and preparation method thereof | |
AU2016313671A1 (en) | Health food and process for preparing the same | |
CN105596401A (en) | Assistant hypoglycemic momordica grosvenori preparation and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180524 Address after: 051430 No. 168, Shi Luan street, Luancheng District, Shijiazhuang, Hebei. Applicant after: China Shineway Pharmaceutical Group Co., Ltd. Applicant after: Beijing Tianjin Hebei LIAN pharmaceutical research (Beijing) Co., Ltd. Address before: 051430 No. 168, Shek Luan street, Luancheng District, Shijiazhuang, Hebei. Applicant before: China Shineway Pharmaceutical Group Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |